Sharemaestro Newsreel

Illumina-Aktie meldet 1,16 Mrd. USD Umsatz im Q2 2026

Illumina (ILMN) Tests Valuation As Russell Index Removal Forces A Fresh Look

Index removal puts Illumina in focus Illumina (ILMN) has been removed from the Russell Small Cap Value Index, an index reshuffle that can prompt mechanical selling and raise fresh questions about how the stock is being valued today. The index removal comes at a …

QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation

Compact system offers research laboratories a time-saving and cost-efficient way to automate work still done by hand Reduction in hands-on time of over 80% compared with manual sample processing Third new sample preparation system launched in 2026 expands automation portfolio from small research labs …

Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now

QIAGEN N.V. QGEN is well positioned for growth in the upcoming quarters, supported by continued test menu expansion. Meanwhile, strategic partnerships support assay development and create opportunities for recurring consumables revenues across clinical, research and biopharma markets. However, cautious customer spending, weaker research funding …

Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question

Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return …

Eurofins Scientific: Director/PDMR Shareholding

LUXEMBOURG, September 24, 2026--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. …

Danaher (DHR) Stock Looks Reasonable On Label Free Detection Growth

Danaher has delivered a 17.4% gain over the past year, which puts a spotlight on one core issue for anyone looking at the stock today: whether the current share price can be explained by the cash flows the business is expected to generate. The …

Should You Continue to Hold IDXX Stock in Your Portfolio?

IDEXX Laboratories, Inc. IDXX is strengthening its Companion Animal Group ("CAG") business through recurring revenue growth, wider customer adoption and expanding diagnostic offerings. Software adoption continues to expand, with recurring revenues, cloud-native PIMS and Vello active users all posting double-digit growth. The company's international …

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: …

Die IDEXX-Laboratories-Aktie notiert nahe dem Jahrestief

Danaher Schedules Third Quarter 2026 Earnings Conference Call

WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2026 on Wednesday, October 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the …

Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030

Company Logo AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-Free Detection - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. …

Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue

Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "High Content Screening (HCS) - Global Strategic Business Report" has …

Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI

Company Logo AI, automation, robotics, microfluidics and nanotechnology are advancing HTS, while personalized medicine, biologics, research funding and pharma-academia partnerships drive demand. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "High Throughput Screening (HTS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. …

Eurofins Scientific SE: Director/PDMR Shareholding

LUXEMBOURG, September 21, 2026--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse …

Eurofins: Weekly Report on Share Repurchases From 14th September to 18th September 2026

LUXEMBOURG, September 21, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS …

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. IDEXX reaffirmed its long-term growth targets of more than 10% organic revenue growth and more than 15% EPS growth, supported by recurring-revenue momentum and a large, underpenetrated veterinary diagnostics market. …

Illumina Stock Is Up 133% This Year. Here’s Where It Could Go Further.

Illumina Stock Is Up 133% This Year. Here's Where It Could Go Further. ©TIKR Key Takeaways Year-Long Surge: Illumina stock has climbed 133% over the past year, closing at $240 on September 18, 2026, up from roughly $103 twelve months earlier. Street Split: Illumina …

IQVIA Holdings (IQV) Prices $2b Notes, Does The Stock Look Fairly Valued?

IQVIA Holdings (IQV) has just priced a US$2b senior notes offering due 2034, a sizable refinancing move that reshapes its debt stack and gives investors fresh information on the company's funding costs and capital structure. Over the past year IQVIA Holdings has delivered a …

IQVIA (IQV) Stock Could Be Undervalued After Its 42% Run

IQVIA Holdings has delivered a strong share-price run recently, which naturally puts more focus on whether the cash it is expected to generate can support the current valuation. With the stock now trading in a different zone to where it sat a year ago, …

IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics

On September 16, IDEXX Laboratories (NASDAQ:IDXX) announced it had bought CoVetAI, a fast-growing veterinary software company whose tool listens during appointments and organizes what gets said and done. It sounds like a productivity gadget. But IDEXX is pitching it as a way to put …

QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board

VENLO, Netherlands, September 18, 2026--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will hold an Extraordinary General Meeting of Shareholders on November 6, 2026, at 2:00 p.m. CET. Shareholders will be asked to vote on the appointment of Jonathan …

Thermo Fisher Scientific (TMO) is Positioned for Resurgence

Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time …

IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide

IDEXX Laboratories has seen a mixed share price story in recent years, and the question now is whether its current US$506.48 level lines up with the cash flows the business may generate over time. Recent price pressure and fresh AI-driven software ambitions are pulling …

IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus

IDEXX Laboratories (IDXX) drew fresh attention after expanding its Faecal Dx antigen testing platform in the United Kingdom to cover taeniid tapeworms, including Taenia and Echinococcus species, during routine veterinary visits. Recent moves by IDEXX Laboratories, including the Faecal Dx expansion and the CoVetAI …

Three Analysts, Three Verdicts on Thermo Fisher: Here’s Who the Numbers Favor

Three Analysts, Three Verdicts on Thermo Fisher: Here's Who the Numbers Favor ©TIKR Key Stats for Thermo Fisher Stock Current Price: $641.39 Target Price (Mid): ~$839 Street Target: ~$645 Potential Total Return: ~31% Annualized IRR: ~7% / year What Happened? Thermo Fisher Scientific (TMO) …

Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform?

Thermo Fisher Scientific (NYSE:TMO) and Mayo Clinic announced the formation of Precure, LLC for early disease detection using multi omic data. Precure plans to integrate proteomic, genomic, and longitudinal clinical records into a single biomedical dataset to identify early disease signals. The collaboration positions …

IDEXX Stock Gains Following the Acquisition of CoVet

IDEXX Laboratories, Inc. IDXX recently announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The acquisition of CoVet reinforces software and AI as strategic enablers of diagnostic insights, workflow …

Qiagen Shares Rise 4% Following Report of Private Equity Takeover Interest

Is IDEXX’s Expanded Zoonosis Testing Menu Altering The Investment Case For IDEXX Laboratories (IDXX)?

IDEXX Laboratories recently expanded its Faecal Dx antigen testing platform in the United Kingdom to include taeniid tapeworm detection, broadening routine intestinal parasite screening to seven clinically relevant parasite groups and triggering automatic, complimentary Echinococcus RealPCR follow-up tests for positive cases. This expansion deepens …

Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’

Key Points Interested in Thermo Fisher Scientific Inc.? Here are five stocks we like better. Thermo Fisher raised its outlook after returning to 5% organic growth in the second quarter, with adjusted EPS up 13%. CEO Marc Casper expects about 4% organic growth in …

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

Expanded testing menu now detects more intestinal parasites during routine visits WESTBROOK, Maine, September 17, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx™ antigen testing platform in the United Kingdom with …

QIAGEN (QGEN) Rolls Out QIAsymphony Connect Following Q2 Outperformance

On August 27, QIAGEN N.V. (NYSE:QGEN) launched QIAsymphony Connect, a new automated platform for clinical nucleic acid extraction aimed at laboratories running liquid biopsy, oncology, and infectious disease tests. The timing is notable. On August 5, QIAGEN had already posted second-quarter results that beat …